company background image
NIG-

Nigerian-German ChemicalsNGSE:NIG-GERMAN Stock Report

Market Cap

₦556.7m

7D

0%

1Y

0%

Updated

21 Oct, 2021

Data

Company Financials
NIG-GERMAN fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

NIG-GERMAN Overview

Nigerian-German Chemicals PLC manufactures and distributes specialty industrial chemicals and pharmaceuticals.

Price History & Performance

Summary of all time highs, changes and price drops for Nigerian-German Chemicals
Historical stock prices
Current Share Price₦3.62
52 Week High₦0
52 Week Low₦0
Beta0
1 Month Change0%
3 Month Change0%
1 Year Change0%
3 Year Change0%
5 Year Change0%
Change since IPO10.37%

Recent News & Updates

Shareholder Returns

NIG-GERMANNG PharmaceuticalsNG Market
7D0%1.4%1.4%
1Y0%39.0%41.3%

Return vs Industry: NIG-GERMAN underperformed the NG Pharmaceuticals industry which returned 39.5% over the past year.

Return vs Market: NIG-GERMAN underperformed the NG Market which returned 40.4% over the past year.

Price Volatility

Is NIG-GERMAN's price volatile compared to industry and market?
NIG-GERMAN volatility
NIG-GERMAN Beta0
Industry Beta0.56
Market Beta1

Stable Share Price: NIG-GERMAN is less volatile than 75% of NG stocks over the past 3 months, typically moving +/- 0% a week.

Volatility Over Time: NIG-GERMAN's weekly volatility (0%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1963n/aAdeboye Shonekanhttps://www.ngc.ng

Nigerian-German Chemicals PLC manufactures and distributes specialty industrial chemicals and pharmaceuticals. It also provides agrochemicals, such as herbicides, fungicides and insecticides; household consumer products, including disinfectants, insecticides, detergents, bleaches, personal care products, hygiene products, and air fresheners; veterinary/animal healthcare products consisting of anthelmintics, ecto-parasite remedies, anti-infectives, anti rabies vaccines, and fed additives; and oil and gas products comprising demulsifiers, flow improvers, biocides, corrosion inhibitors, flocculants, wax inhibitors, and scale inhibitors. The company was founded in 1963 and is based in Ota, Nigeria.

Nigerian-German Chemicals Fundamentals Summary

How do Nigerian-German Chemicals's earnings and revenue compare to its market cap?
NIG-GERMAN fundamental statistics
Market Cap₦556.71m
Earnings (TTM)₦131.14m
Revenue (TTM)₦3.01b

0x

P/E Ratio

0x

P/S Ratio

Is NIG-GERMAN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
NIG-GERMAN income statement (TTM)
Revenue₦3.01b
Cost of Revenue₦1.61b
Gross Profit₦1.40b
Expenses₦1.27b
Earnings₦131.14m

Last Reported Earnings

Mar 31, 2013

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did NIG-GERMAN perform over the long term?

See historical performance and comparison

Valuation

Is Nigerian-German Chemicals undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Nigerian-German Chemicals is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Nigerian-German Chemicals has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Future Growth

How is Nigerian-German Chemicals forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

14.3%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nigerian-German Chemicals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Nigerian-German Chemicals performed over the past 5 years?

12.8%

Historical Pharmaceuticals & Biotech annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Nigerian-German Chemicals has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Financial Health

How is Nigerian-German Chemicals's financial position?


In this section we usually analyse Nigerian-German Chemicals's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Nigerian-German Chemicals has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Dividend

What is Nigerian-German Chemicals's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate NIG-GERMAN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NIG-GERMAN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if NIG-GERMAN's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NIG-GERMAN's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of NIG-GERMAN's dividend in 3 years as they are not forecast to pay a notable one for the NG market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

22.5yrs

Average management tenure


CEO

Adeboye Shonekan

22.5yrs

Tenure

Mr. Adeboye Shonekan has been the Chief Executive Officer at Nigerian-German Chemicals PLC since April 27, 1999. Mr. Shonekan joined Nigerian-German in 1995 as an Executive Director and was responsible for...


Leadership Team

Experienced Management: NIG-GERMAN's management team is seasoned and experienced (22.5 years average tenure).


Board Members

Experienced Board: NIG-GERMAN's board of directors are seasoned and experienced ( 11.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Nigerian-German Chemicals PLC's employee growth, exchange listings and data sources


Key Information

  • Name: Nigerian-German Chemicals PLC
  • Ticker: NIG-GERMAN
  • Exchange: NGSE
  • Founded: 1963
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: ₦556.705m
  • Shares outstanding: 153.79m
  • Website: https://www.ngc.ng

Location

  • Nigerian-German Chemicals PLC
  • Km 38, Lagos-Abeokuta Expressway
  • Ota
  • Nigeria

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/21 20:59
End of Day Share Price2021/10/21 00:00
Earnings2013/03/31
Annual Earnings2013/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.